Related Experiment Video
Updated: Jun 4, 2026
08:34
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
A planning study for palliative spine treatment using StatRT and megavoltage CT simulation
Yi Rong1, Poonam Yadav, Bhudatt Paliwal
1Department of Human Oncology, University of Wisconsin Madison, Madison, WI, USA. rongyi@gmail.com
Journal of Applied Clinical Medical Physics
|February 19, 2011
Summary
StatRT, a new TomoTherapy feature, enables megavoltage CT (MVCT) scanning, planning, and delivery in one session. This technique is clinically feasible for palliative treatment, significantly reducing overall treatment time for patients with metal artifacts.
Area of Science:
- Radiation Oncology
- Medical Physics
- Radiotherapy Technology
Background:
- Conventional CT simulation can be limited by severe metal artifacts, hindering accurate treatment planning.
- Megavoltage CT (MVCT) simulation offers an alternative for patients with metallic implants, such as spinal hardware.
- Severe artifacts from spinal stabilizing rods prevented effective treatment planning using conventional kilovoltage CT.
Purpose of the Study:
- To describe the clinical feasibility of the StatRT technique using MVCT for palliative treatment in a patient with substantial spinal metallic hardware.
- To compare treatment plans generated by StatRT with conventional tomotherapy planning methods.
- To evaluate the efficiency and time savings associated with the StatRT procedure.
Main Methods:
- A patient with metastatic non-small-cell lung cancer and spinal metallic hardware underwent MVCT simulation on a TomoTherapy unit.
- Treatment plans were generated using StatRT and conventional tomotherapy planning (Tomo plan) with varying settings and iterations.
- Dosimetric evaluation included DVH analysis and dose distribution comparisons to organs at risk and targets.
Main Results:
- StatRT planning, completed in 10-15 minutes, yielded a DVH almost identical to a conventional Tomo plan using the "full scatter" mode.
- Dose distributions to the heart, lungs, and targets were comparable across StatRT, "full scatter", and "beamlet" modes.
- The overall treatment process time was reduced to approximately 40 minutes using the StatRT procedure, compared to hours previously.
Conclusions:
- StatRT is a clinically feasible tool for MVCT-based treatment planning and delivery in a single session.
- The technique significantly reduces treatment time, making it beneficial for urgent palliative care.
- StatRT provides comparable dosimetric outcomes to conventional tomotherapy planning, even in the presence of severe metal artifacts.
